Feng Chi Biotech Corp. (6744.TWO)
TWD 19.7
(0.0%)
TWD 19.7
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 10.79 Million TWD | -19.92% |
| 2022 | 13.48 Million TWD | 428.78% |
| 2021 | 2.55 Million TWD | -51.56% |
| 2020 | 5.26 Million TWD | 0.0% |
| 2019 | 5.26 Million TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 6.79 Million TWD | 39.5% |
| 2024 Q1 | 6.79 Million TWD | -37.04% |
| 2023 Q1 | 9.48 Million TWD | -29.68% |
| 2023 FY | 10.79 Million TWD | -19.92% |
| 2023 Q4 | 10.79 Million TWD | 32.51% |
| 2023 Q3 | 8.14 Million TWD | -33.22% |
| 2023 Q2 | 12.2 Million TWD | 28.7% |
| 2022 Q4 | 13.48 Million TWD | 24.87% |
| 2022 FY | 13.48 Million TWD | 428.78% |
| 2022 Q3 | 10.79 Million TWD | 0.0% |
| 2021 FY | 2.55 Million TWD | -51.56% |
| 2020 FY | 5.26 Million TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 90.482% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 96.193% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -1141.149% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 95.98% |
| NaviFUS Corp. | 32.69 Million TWD | 66.972% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -98.822% |
| TaiRx, Inc. | 12.28 Million TWD | 12.111% |
| Sinew Pharma Inc. | 6.46 Million TWD | -67.048% |
| Lin BioScience, Inc. | 42.87 Million TWD | 74.814% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -822.118% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 14.37% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -680.766% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 97.319% |
| AP Biosciences Inc | 82.07 Million TWD | 86.844% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 93.797% |
| RBC Bioscience Corporation | 487.36 Million TWD | 97.784% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 98.416% |
| EirGenix Inc. | 465.16 Million TWD | 97.679% |
| Enimmune corporation | 45.73 Million TWD | 76.39% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 86.92% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -200.612% |
| 3D Global Biotech Inc. | 10.37 Million TWD | -4.037% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 98.562% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 98.513% |
| TCI GENE Inc. | 6.79 Million TWD | -58.911% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -410.785% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 97.287% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -148.002% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 88.856% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | -35.466% |
| Neith Corporation | 3.54 Million TWD | -204.942% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 97.241% |
| VBI | - TWD | -Infinity% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -83.079% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 95.799% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -1907.063% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 60.186% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -29.815% |
| Visgeneer Inc. | 158.6 Million TWD | 93.192% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 94.495% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 81.449% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 97.411% |
| Sagittarius Life Science Corp | 13.32 Million TWD | 18.952% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 17.522% |
| GlycoNex Incorporation | 900 Thousand TWD | -1099.778% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.629% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 92.521% |
| PharmaEngine, Inc. | 14.8 Million TWD | 27.085% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 99.248% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 96.627% |
| BiOptic Inc. | 93.19 Million TWD | 88.414% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 85.542% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | -12.467% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -1.086% |
| OBI Pharma, Inc. | 501.05 Million TWD | 97.845% |
| Savior Lifetec Corporation | 270.37 Million TWD | 96.006% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 24.883% |
| Level Biotechnology Inc. | 13.5 Million TWD | 20.027% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.453% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | 68.278% |
| Acepodia, Inc. | 273.81 Million TWD | 96.056% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 47.219% |